Ratos (RATO) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Adjusted EBITA grew 2% year-over-year to SEK 1,101m, with margin improving to 12.1% despite a 9% drop in net sales, driven by strong order intake and operational improvements in most segments.
Profit for the period increased 8% to SEK 735m, and diluted EPS was SEK 1.85, up from SEK 1.79.
Cash flow and cash conversion were robust, with a 127% cash conversion rate and significant reductions in net working capital and inventory.
Construction and services delivered a strong EBITDA/EBITA margin increase despite weak market conditions and lower sales.
Consumer segment, particularly Plantasjen, underperformed due to adverse weather, but cost-saving measures are ongoing.
Financial highlights
Net sales declined 9% year-over-year (10% organically) in Q2, with LTM net sales at SEK 32.9 billion.
Adjusted EBITA grew 2% year-over-year, reaching SEK 2,302m LTM, and operating profit was SEK 1,070m (up 3%).
Cash flow from operating activities was SEK 1,397m, with cash conversion at 127%.
Net working capital reduced to 0.8% of LTM net sales, with significant inventory reductions in Plantasjen and Diab.
Leverage decreased to 0.7x, with net debt at SEK 3,091m and down by SEK 650–700 million.
Outlook and guidance
Construction and services expected to maintain strong margins due to improved processes and robust project portfolios.
Cost-saving programs in Plantasjen will continue, with further effects anticipated in Q3 and Q4.
Most new order intake will be delivered from 2025 onwards.
Management expects continued improvement in earnings and profitability, with readiness for structural transactions as market conditions improve.
On track to reach SEK 3bn EBITA target by 2025, with current LTM at SEK 2,302m.
Latest events from Ratos
- Adjusted EBITA rose 17% to SEK 1,931m, with improved leverage and major restructuring.RATO
Q4 20254 Mar 2026 - Strong cash flow and stable earnings offset sales decline amid major restructuring.RATO
Q3 202419 Jan 2026 - Adjusted EBITA rose, but non-recurring items from Plantasjen led to lower reported profit.RATO
Q4 202423 Dec 2025 - Adjusted EBITA up 32% with strong order intake and Plantasjen turnaround.RATO
Q1 202528 Nov 2025 - Margin expansion and major capital gains achieved amid challenging market conditions.RATO
Q2 202516 Nov 2025 - Earnings and margins rose despite lower sales, with strong cash flow and reduced leverage.RATO
Q3 202521 Oct 2025